financetom
Business
financetom
/
Business
/
PRA Group Q2 net income jumps 97% 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRA Group Q2 net income jumps 97% 
Aug 4, 2025 2:07 PM

Overview

* PRA Group ( PRAA ) Q2 net income rises 96.9%, driven by Brazil equity sale gain

* Total cash collections up 13.2%, with improved cash efficiency ratio

* Adjusted EBITDA grows 16.4%, outpacing cash collections growth

Outlook

* PRA Group ( PRAA ) targets $1.2 bln in portfolio purchases for full-year 2025

Result Drivers

* PORTFOLIO PURCHASES - Strong portfolio purchases at attractive returns contributed to record ERC

* BRAZIL EQUITY SALE - Net income includes gain from sale of equity interest in Brazil

* CASH EFFICIENCY - Improved cash efficiency ratio reflects better expense management and increased cash collections

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS $1.08

Q2 Net $42.37

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the corporate financial services peer group is "buy"

* Wall Street's median 12-month price target for PRA Group Inc ( PRAA ) is $23.00, about 34.5% above its August 1 closing price of $15.06

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Organon & Co -On Sept 17, Co & Unit Entered Into Agreement And Plan Of Merger By Dermavant Sciences & Roivant Sciences
BRIEF-Organon & Co -On Sept 17, Co & Unit Entered Into Agreement And Plan Of Merger By Dermavant Sciences & Roivant Sciences
Oct 3, 2024
Organon & Co ( OGN ): * ORGANON & CO ( OGN ) -ON SEPT 17, CO & UNIT ENTERED INTO AGREEMENT AND PLAN OF MERGER BY DERMAVANT SCIENCES & ROIVANT SCIENCES * ORGANON & CO ( OGN ) -PURSUANT TO MERGER, ORGANON TO MERGE WITH AND INTO DERMAVANT, WITH DERMAVANT CONTINUING AS SURVIVING CO * ORGANON & CO (...
BRIEF-WF Holding Currently Estimate The Initial Public Offering Price Will Be Between $4.00 And $6.00 Per Share
BRIEF-WF Holding Currently Estimate The Initial Public Offering Price Will Be Between $4.00 And $6.00 Per Share
Oct 3, 2024
Sept 23 (Reuters) - * WF HOLDING LTD: CURRENTLY ESTIMATE THAT THE INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $4.00 AND $6.00 PER SHARE * WF HOLDING LTD SEES US IPO OF UP TO 2MLN ORDINARY SHARES - SEC FILING * WF HOLDING LTD: HAVE APPLIED TO LIST OUR ORDINARY SHARES ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL WFF...
BRIEF-U.S. SEC Says Ordered That S-1 IPO Filing Filed By Elephant Oil Corp Be Declared Abandoned On Sept 23  - SEC Filing
BRIEF-U.S. SEC Says Ordered That S-1 IPO Filing Filed By Elephant Oil Corp Be Declared Abandoned On Sept 23 - SEC Filing
Oct 3, 2024
Sept 23 (Reuters) - Elephant Oil Corp: * U.S. SEC SAYS ORDERED THAT S-1 IPO FILING FILED BY ELEPHANT OIL CORP BE DECLARED ABANDONED ON SEPT 23 - SEC FILING * U.S. SEC SAYS ELEPHANT OIL CORP WHICH HAD FILED FOR IPO IN MARCH 25, 2022, FAILED TO RESPOND TO SEC'S NOTICE UNDER RULE 479 Source text for Eikon: Further...
BRIEF-Waverley Pharma Acquires Us Based Pharmacy
BRIEF-Waverley Pharma Acquires Us Based Pharmacy
Oct 3, 2024
Waverley Pharma Inc: * WAVERLEY PHARMA ACQUIRES US BASED PHARMACY * WAVERLEY PHARMA INC - DEAL VALUED AT $450,000 WITH POTENTIAL ADDITIONAL $60,000 Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved